Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 5, 2025 • 2:00 PM ET

Date/Time Source News Release
10/23/2024 07:00 AM EDT GlobeNewswire Genenta's CEO to present at the U.S. Senate meeting on "Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective"
10/02/2024 06:30 AM EDT GlobeNewswire Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer
05/06/2024 06:25 AM EDT GlobeNewswire Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider
02/08/2024 05:00 AM EST GlobeNewswire Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid Tumors
09/06/2023 07:00 AM EDT GlobeNewswire Genenta to Present at Upcoming Scientific and Investor Conferences
07/28/2023 03:00 AM EDT GlobeNewswire Genenta Announces Ongoing Clinical Trial Progress and Proposed Expansion in Solid Tumor Treatments
06/29/2023 07:00 AM EDT GlobeNewswire The European Commission Grants Orphan Drug Designation to Temferon(TM) for Treatment of Glioma
05/16/2023 07:00 AM EDT GlobeNewswire Genenta to Provide Update on Lead Product Temferon(TM)
04/26/2023 07:00 AM EDT GlobeNewswire Genenta Announces Fiscal Year 2022 Financial Results and Annual Report on Form 20-F Filing
04/03/2023 07:00 AM EDT GlobeNewswire Genenta Announces Extension of License Agreement with Ospedale San Raffaele to All Solid Tumor Indications
Page

Additional News

As of January 5, 2025 • 2:00 PM ET

Date/Time Source News Release
12/21/2024 11:52 AM EST Stock Traders Daily Where are the Opportunities in (GNTA)
10/10/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Thu, Oct 10, 2024 as of 10.00 am ET
07/18/2024 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Thu, Jul 18, 2024 as of 4:00 pm ET
04/24/2024 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Wed, Apr 24, 2024 as of 4:00 pm ET
04/24/2024 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Wednesday, April 24th, 2024
04/24/2024 05:36 AM EDT US Earnings Reports Expected earnings - Genenta Science S.p.A.
03/01/2024 01:30 PM EST InvestorBrandNetwork Genenta Science (NASDAQ: GNTA) Featured in Coverage of the 36th Annual Roth Conference
03/02/2023 07:04 AM EST SeekingAlpha Genenta's brain cancer cell therapy gets FDA orphan drug status
02/07/2023 08:18 AM EST SeekingAlpha Genenta expands pact with AGC Biologics to make cell therapy products for trials
10/24/2022 08:45 AM EDT SeekingAlpha Genenta Science  GAAP EPS of Euro0.27 beats by Euro0.42
Page
  • 1
  • 2